Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

16S rRNA gene primer choice impacts off-target amplification in human gastrointestinal tract biopsies and microbiome profiling

T. Deissová, M. Zapletalová, L. Kunovský, R. Kroupa, T. Grolich, Z. Kala, P. Bořilová Linhartová, J. Lochman

. 2023 ; 13 (1) : 12577. [pub] 20230803

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

16S rRNA amplicon sequencing or, more recently, metatranscriptomic analysis are currently the only preferred methods for microbial profiling of samples containing a predominant ratio of human to bacterial DNA. However, due to the off-target amplification of human DNA, current protocols are inadequate for bioptic samples. Here we present an efficient, reliable, and affordable method for the bacteriome analysis of clinical samples human DNA content predominates. We determined the microbiota profile in a total of 40 human biopsies of the esophagus, stomach, and duodenum using 16S rRNA amplicon sequencing with the widely used 515F-806R (V4) primers targeting the V4 region, 68F-338R primers and a modified set of 68F-338R (V1-V2M) primers targeting the V1-V2 region. With the V4 primers, on average 70% of amplicon sequence variants (ASV) mapped to the human genome. On the other hand, this off-target amplification was absent when using the V1-V2M primers. Moreover, the V1-V2M primers provided significantly higher taxonomic richness and reproducibility of analysis compared to the V4 primers. We conclude that the V1-V2M 16S rRNA sequencing method is reliable, cost-effective, and applicable for low-bacterial abundant human samples in medical research.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016613
003      
CZ-PrNML
005      
20231026105657.0
007      
ta
008      
231013s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-023-39575-8 $2 doi
035    __
$a (PubMed)37537336
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Deissová, Tereza $u Department of Biochemistry, Faculty of Science, Masaryk University, Kamenice 735/5, 62500, Brno, Czech Republic
245    10
$a 16S rRNA gene primer choice impacts off-target amplification in human gastrointestinal tract biopsies and microbiome profiling / $c T. Deissová, M. Zapletalová, L. Kunovský, R. Kroupa, T. Grolich, Z. Kala, P. Bořilová Linhartová, J. Lochman
520    9_
$a 16S rRNA amplicon sequencing or, more recently, metatranscriptomic analysis are currently the only preferred methods for microbial profiling of samples containing a predominant ratio of human to bacterial DNA. However, due to the off-target amplification of human DNA, current protocols are inadequate for bioptic samples. Here we present an efficient, reliable, and affordable method for the bacteriome analysis of clinical samples human DNA content predominates. We determined the microbiota profile in a total of 40 human biopsies of the esophagus, stomach, and duodenum using 16S rRNA amplicon sequencing with the widely used 515F-806R (V4) primers targeting the V4 region, 68F-338R primers and a modified set of 68F-338R (V1-V2M) primers targeting the V1-V2 region. With the V4 primers, on average 70% of amplicon sequence variants (ASV) mapped to the human genome. On the other hand, this off-target amplification was absent when using the V1-V2M primers. Moreover, the V1-V2M primers provided significantly higher taxonomic richness and reproducibility of analysis compared to the V4 primers. We conclude that the V1-V2M 16S rRNA sequencing method is reliable, cost-effective, and applicable for low-bacterial abundant human samples in medical research.
650    _2
$a lidé $7 D006801
650    _2
$a RNA ribozomální 16S $x genetika $7 D012336
650    _2
$a geny rRNA $7 D020459
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a sekvenční analýza DNA $x metody $7 D017422
650    12
$a mikrobiota $x genetika $7 D064307
650    _2
$a gastrointestinální trakt $7 D041981
650    _2
$a biopsie $7 D001706
650    _2
$a vysoce účinné nukleotidové sekvenování $x metody $7 D059014
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Zapletalová, Martina $u Department of Biochemistry, Faculty of Science, Masaryk University, Kamenice 735/5, 62500, Brno, Czech Republic
700    1_
$a Kunovský, Lumír $u Department of Gastroenterology and Internal Medicine, University Hospital Brno, and Faculty of Medicine, Masaryk, University, Jihlavská 20, 62500, Brno, Czech Republic $u Department of Surgery, University Hospital Brno, and Faculty of Medicine, Masaryk University, Jihlavská 20, 62500, Brno, Czech Republic
700    1_
$a Kroupa, Radek $u Department of Gastroenterology and Internal Medicine, University Hospital Brno, and Faculty of Medicine, Masaryk, University, Jihlavská 20, 62500, Brno, Czech Republic
700    1_
$a Grolich, Tomáš $u Department of Gastroenterology and Internal Medicine, University Hospital Brno, and Faculty of Medicine, Masaryk, University, Jihlavská 20, 62500, Brno, Czech Republic
700    1_
$a Kala, Zdeněk $u Department of Surgery, University Hospital Brno, and Faculty of Medicine, Masaryk University, Jihlavská 20, 62500, Brno, Czech Republic
700    1_
$a Bořilová Linhartová, Petra $u Department of Pathophysiology, Faculty of Medicine, Masaryk University, Jihlavská 20, 62500, Brno, Czech Republic $u Faculty of Science, RECETOX, Masaryk University, Kotlářská 2, Brno, Czech Republic
700    1_
$a Lochman, Jan $u Department of Biochemistry, Faculty of Science, Masaryk University, Kamenice 735/5, 62500, Brno, Czech Republic. jlochman@sci.muni.cz $u Department of Pathophysiology, Faculty of Medicine, Masaryk University, Jihlavská 20, 62500, Brno, Czech Republic. jlochman@sci.muni.cz
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 13, č. 1 (2023), s. 12577
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37537336 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026105652 $b ABA008
999    __
$a ok $b bmc $g 2000248 $s 1202975
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 13 $c 1 $d 12577 $e 20230803 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20231013

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...